Investor Relations Corporate ProfileAssembly Bio aspires to deliver innovative small molecule antiviral therapeutics designed to change the path of serious viral and liver diseases and improve the lives of patients worldwide. Minimum 15 minutes delayed. Source: LSEG Press Releases See all news Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates Events & Presentations See all upcoming events Sep 16, 2026 at 8:30 AM EDT H.C. Wainwright 28th Annual Global Investment Conference – Fireside Chat Jun 8, 2026 at 8:40 AM EDT Goldman Sachs Global Conference Jun 3, 2026 at 4:20 PM EDT Jefferies 2026 Global Healthcare Conference - Fireside Chat Shareholder Tools Print Email Alerts RSS News Feeds Search Investors
Investor Relations Corporate ProfileAssembly Bio aspires to deliver innovative small molecule antiviral therapeutics designed to change the path of serious viral and liver diseases and improve the lives of patients worldwide. Minimum 15 minutes delayed. Source: LSEG Press Releases See all news Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates Events & Presentations See all upcoming events Sep 16, 2026 at 8:30 AM EDT H.C. Wainwright 28th Annual Global Investment Conference – Fireside Chat Jun 8, 2026 at 8:40 AM EDT Goldman Sachs Global Conference Jun 3, 2026 at 4:20 PM EDT Jefferies 2026 Global Healthcare Conference - Fireside Chat
